和邦生物
(603077)
| 流通市值：154.55亿 | | | 总市值：154.55亿 |
| 流通股本：88.31亿 | | | 总股本：88.31亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 7,120,398,954.88 | 6,999,422,872.19 | 2,566,744,701.12 | 3,061,371,846.19 |
| 应收票据及应收账款 | 880,412,271.8 | 809,763,164.93 | 1,125,936,161.17 | 1,069,034,187.55 |
| 应收账款 | 880,412,271.8 | 809,763,164.93 | 1,125,936,161.17 | 1,069,034,187.55 |
| 应收款项融资 | 745,485,499.12 | 1,211,259,933.57 | 1,671,842,955.2 | 1,935,542,344.58 |
| 预付款项 | 193,893,890.22 | 205,432,194.96 | 291,427,093.27 | 213,653,426.23 |
| 其他应收款合计 | 42,142,152.46 | 30,071,895.93 | 71,160,979.01 | 31,161,611.82 |
| 存货 | 4,665,159,566.53 | 4,544,934,762.69 | 4,915,503,894.89 | 4,668,904,435.2 |
| 合同资产 | 39,775,621.45 | 21,823,366.6 | 23,043,247.34 | 27,089,397.78 |
| 其他流动资产 | 188,208,323.04 | 180,561,265.76 | 162,623,323.32 | 128,752,115.85 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 13,875,476,279.5 | 14,003,269,456.63 | 10,828,282,355.32 | 11,135,509,365.2 |
| 非流动资产: | | | | |
| 长期股权投资 | 75,614,059.3 | 51,069,620.54 | 20,270,029.71 | - |
| 其他权益工具投资 | 359,235,510.07 | 341,106,630.13 | 339,807,968.23 | 359,757,145.82 |
| 其他非流动金融资产 | 465,278,185.83 | 465,278,185.83 | 459,278,185.83 | 459,278,185.83 |
| 固定资产 | 7,148,695,205.64 | 7,567,419,056.88 | 7,890,436,819.61 | 8,073,685,971.44 |
| 在建工程 | 2,784,181,094.54 | 2,354,469,430.77 | 1,881,750,227.09 | 1,663,369,519.2 |
| 使用权资产 | 27,965,691.69 | 30,023,932.51 | 38,735,361.94 | 33,723,112.19 |
| 无形资产 | 2,648,232,196 | 2,388,894,110.44 | 2,173,521,410.62 | 2,185,425,067.74 |
| 开发支出 | 186,136,501.1 | 173,254,914.06 | 155,296,418.97 | 129,942,826.35 |
| 商誉 | 1,838,405,543.83 | 1,838,405,543.83 | 1,838,405,543.83 | 1,838,405,543.83 |
| 长期待摊费用 | 1,128,301.91 | 1,226,415.11 | 3,940,826.18 | 4,245,121.4 |
| 递延所得税资产 | 127,989,543.43 | 127,226,004.13 | 59,149,574.59 | 51,334,435.64 |
| 其他非流动资产 | 306,611,137.21 | 308,091,239.02 | 286,437,958 | 288,233,407.6 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 15,969,472,970.55 | 15,646,465,083.25 | 15,147,030,324.6 | 15,087,400,337.04 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 29,844,949,250.05 | 29,649,734,539.88 | 25,975,312,679.92 | 26,222,909,702.24 |
| 流动负债: | | | | |
| 短期借款 | 2,517,829,345.58 | 2,353,237,189.55 | 2,230,354,327.07 | 2,194,229,420.04 |
| 应付票据及应付账款 | 1,543,200,932.55 | 2,107,642,884.06 | 2,748,265,511.61 | 2,829,213,851.1 |
| 其中：应付票据 | 95,627,507.68 | 669,343,934.47 | 1,288,055,739.4 | 1,279,173,444.36 |
| 应付账款 | 1,447,573,424.87 | 1,438,298,949.59 | 1,460,209,772.21 | 1,550,040,406.74 |
| 合同负债 | 115,662,092.46 | 45,100,553.29 | 75,424,330.17 | 78,426,487.18 |
| 应付职工薪酬 | 46,632,058.53 | 57,939,446.54 | 52,331,882.49 | 48,384,496.45 |
| 应交税费 | 55,435,464.02 | 34,933,171.55 | 42,139,251.77 | 67,763,638.09 |
| 其他应付款合计 | 31,171,419.87 | 19,225,866.29 | 29,626,233.65 | 24,598,603.81 |
| 一年内到期的非流动负债 | 600,835,022.89 | 751,978,245.32 | 577,351,508.21 | 445,536,214.22 |
| 其他流动负债 | 12,297,518.93 | 4,451,202.01 | 6,738,114.43 | 5,775,221.56 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 4,923,063,854.83 | 5,374,508,558.61 | 5,762,231,159.4 | 5,693,927,932.45 |
| 非流动负债: | | | | |
| 长期借款 | 1,664,892,188.97 | 766,438,037.89 | 604,286,513.58 | 684,654,393.07 |
| 应付债券 | 4,200,345,384.44 | 4,169,656,332.92 | - | - |
| 租赁负债 | 13,139,663.93 | 14,524,544.67 | 28,077,669.3 | 21,957,154.31 |
| 递延收益 | 129,231,082.66 | 130,165,835.17 | 69,818,587.68 | 70,753,340.19 |
| 递延所得税负债 | 188,917,155.19 | 187,923,024.98 | 130,109,851.93 | 134,052,696.95 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 6,196,525,475.19 | 5,268,707,775.63 | 832,292,622.49 | 911,417,584.52 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 11,119,589,330.02 | 10,643,216,334.24 | 6,594,523,781.89 | 6,605,345,516.97 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 8,831,250,228 | 8,831,250,228 | 8,831,250,228 | 8,831,250,228 |
| 其他权益工具 | 364,221,097.83 | 364,221,097.83 | - | - |
| 资本公积 | 944,532,765.14 | 1,034,783,513.95 | 1,153,019,025.48 | 1,141,230,036.47 |
| 减:库存股 | 1,789,756,980.29 | 1,696,878,905.84 | 1,689,756,923.84 | 1,444,939,940.79 |
| 其他综合收益 | 3,414,605.59 | -8,853,745.01 | 21,217,804.82 | 34,737,440.25 |
| 专项储备 | 24,726,214.52 | 23,787,328.03 | 20,211,097.81 | 18,571,725.65 |
| 盈余公积 | 600,422,803.2 | 600,422,803.2 | 589,816,235.79 | 589,816,235.79 |
| 未分配利润 | 9,490,177,424.66 | 9,477,660,111.71 | 9,838,942,269.45 | 9,807,819,549.19 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 18,468,988,158.65 | 18,626,392,431.87 | 18,764,699,737.51 | 18,978,485,274.56 |
| 少数股东权益 | 256,371,761.38 | 380,125,773.77 | 616,089,160.52 | 639,078,910.71 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 18,725,359,920.03 | 19,006,518,205.64 | 19,380,788,898.03 | 19,617,564,185.27 |
| 负债和股东权益合计 | 29,844,949,250.05 | 29,649,734,539.88 | 25,975,312,679.92 | 26,222,909,702.24 |
| 公告日期 | 2025-04-29 | 2025-04-29 | 2024-10-31 | 2024-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |